CHOP researchers have revealed the molecular mechanics of a cell-surface molecule that is a potential immunotherapy target.

Despite maintaining relatively high overall screening rates, canceled well-child visits and incomplete screenings may impact early intervention.

While diagnostic rates were similar, challenges related to sample collection and overcoming barriers to care persist.

CHOP researchers have tested and developed an “off-the-shelf” chimeric antigen receptor T-cell (CART) using base editing.

CHOP researchers have integrated environmental, genetic, and imaging data to better understand which factors might be clinically relevant when it comes to psychiatric and cognitive outcomes.

While telemedicine appeared to be effective in 95% of cases, some younger patients and those with neuromuscular disorders still required in-person visits.

Prestigious award recognizes Dr. High’s contribution to improving children’s health through her gene therapy research, which began during her time at CHOP.

CHOP researchers have developed new software called CancerVar, which helps researchers assess the clinical impacts of over 13 million somatic cancer mutations.

CHOP researchers found neighborhood characteristics were associated with higher rates of SARS-CoV-2 in pregnancy during the prevaccination era of the COVID-19 pandemic.

While the benefits of exercise may outweigh the risks, genetic status should be considered when recommending it as therapy.